Back

Coronary vasomotor disorders in ANOCA patients: insights from the CADOSA registry.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Ischaemia without obstructive disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sarena La

Adelaide University, Adelaide (Australia)

6 More presentations in this session

Presentation thumbnail
Myocardial microvascular dysfunction in asymptomatic patients with hereditary dyslipidemia
Doctor T. Wodaje (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of patients with ischemia and no obstructive coronary artery disease (INOCA) - a systematic review and meta-analysis
Doctor N. Odanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Resting and stress coronary flow velocity for identification of different endotypes and risk classes in ANOCA patients beyond coronary flow velocity reserve
Doctor N. Gaibazzi (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on the association of vascular endothelial growth factor D with cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study
Professor K. Hasegawa (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Improvement of symptoms and quality of life in patients with coronary vasomotion disorders by endotype-based drug therapy
Professor P. Ong (Stuttgart, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Ischaemia without obstructive disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Health outcomes in patients with chronic coronary syndromes due to obstructive or non-obstructive coronary arteries.
thumbnail
Congress Presentation
Does ischaemia testing predict worse adverse outcomes in ANOCA patients?
thumbnail
Congress Presentation
Differences in clinical characteristics, angina, and quality of life among patients with microvascular vs vasospastic angina and no obstructive coronary artery disease (ANOCA)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources